Issues in clinical trial design .2. Selection of end point measures

被引：3

作者：

Bromberg, MB

Brooks, BR

机构：

[1] UNIV WISCONSIN HOSP,ALS CLIN RES CTR,MADISON,WI

[2] CLIN & WILLIAM S MIDDLETON MEM VET HOSP,GREAT LAKES VET INTEGRATED SERV NETWORK 12,MADISON,WI

来源：

NEUROLOGY | 1996年 / 47卷 / 04期

关键词：

D O I：

10.1212/WNL.47.4_Suppl_2.100S

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S100 / S102

页数：3

共 20 条

[1] QUANTITATIVE MOTOR-ASSESSMENT IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].

ANDRES, PL ;

HEDLUND, W ;

FINISON, L ;

CONLON, T ;

FELMUS, M ;

MUNSAT, TL .

NEUROLOGY, 1986, 36 (07) :937-941

[2] USE OF COMPOSITE SCORES (MEGASCORES) TO MEASURE DEFICIT IN AMYOTROPHIC LATERAL SCLEROSIS [J].

ANDRES, PL ;

FINISON, LJ ;

CONLON, T ;

THIBODEAU, LM ;

MUNSAT, TL .

NEUROLOGY, 1988, 38 (03) :405-408

[3]

BEASLEY W C, 1961, Arch Phys Med Rehabil, V42, P398

[4] A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].

BENSIMON, G ;

LACOMBLEZ, L ;

MEININGER, V ;

BOUCHE, P ;

DELWAIDE, C ;

COURATIER, P ;

BLIN, O ;

VIADER, F ;

PEYROSTPAUL, H ;

DAVID, J ;

MALOTEAUX, JM ;

HUGON, J ;

LATERRE, EC ;

RASCOL, A ;

CLANET, M ;

VALLAT, JM ;

DUMAS, A ;

SERRATRICE, G ;

LECHEVALLIER, B ;

PEUCH, AJ ;

NGUYEN, T ;

SHU, C ;

BASTIEN, P ;

PAPILLON, C ;

DURRLEMAN, S ;

LOUVEL, E ;

GUILLET, P ;

LEDOUX, L ;

ORVOENFRIJA, E ;

DIB, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :585-591

[5]

BROMBERG MB, IN PRESS J NEUROL S

[6]

BROMBERG MB, 1994, ALS CHARCOT PRESENT, P267

[7]

BROOKS BR, 1995, ADV NEUROL, V68, P163

[8] EL-ESCORIAL WORLD FEDERATION OF NEUROLOGY CRITERIA FOR THE DIAGNOSIS OF AMYOTROPHIC-LATERAL-SCLEROSIS [J].

BROOKS, BR .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 124 :96-107

[9] THE EXTENT AND TIME COURSE OF MOTONEURON INVOLVEMENT IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].

DANTES, M ;

MCCOMAS, A .

MUSCLE & NERVE, 1991, 14 (05) :416-421

[10]

FALLAT RJ, 1994, ALS CHARCOT PRESENT, P309

← 1 2 →